This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Chronic liver failure is a long-term condition that involves the gradual loss of liver function due to a variety of underlying causes. It is a progressive disorder that can lead to cirrhosis and end-stage liver failure. Common causes of chronic liver failure include viral hepatitis, alcohol abuse, fatty liver disease, and autoimmune liver disease. Symptoms of chronic liver failure can include fatigue, jaundice, abdominal pain, loss of appetite, and ascites. The diagnosis of chronic liver failure is made based on medical history, physical examination, laboratory tests, and imaging studies. Common laboratory tests used to diagnose chronic liver failure include liver function tests, liver biopsy, and imaging studies such as ultrasound and CT scan. Treatment of chronic liver failure is dependent on the underlying cause and can include lifestyle modifications, medications, and surgery. Lifestyle changes such as abstaining from alcohol, eating a healthy diet, and exercising regularly can help improve liver function and slow the progression of chronic liver failure. Medications such as antiviral drugs, steroids, and immune system suppressants may be used to treat the underlying cause of the condition. In cases of advanced liver failure, a liver transplant may be necessary. Chronic liver failure can be a serious and life-threatening condition if left untreated. It is important for individuals at risk for chronic liver failure to seek medical attention and follow their doctor's advice. Early diagnosis and treatment can help reduce the risk of complications and improve patient outcomes.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States